1. Medtech Insight
  3. >>Europe
  4. >>Germany

German Medtechs Say MDR Ball Is In EU’s Court, Plus DRG Changes and ESG Reactions

Jury is out on planned market access changes affecting German and EU medtech industries

 
• By Ashley Yeo

Marc-Pierre Möll, CEO of German medtech-industry association BVMed, is hoping for a more collaborative year in 2023 after the health ministry came out with proposals to change the DRGs system and the EU finally conceded that its unhelpful MDR timetable was riding roughshod over the wellbeing of patients.

Shutterstock

In Germany, recent major developments and proposals affecting medical device manufacturers and market access are being appraised by the industry in one of four ways:

These challenges for local medtech manufacturers come at the end of a tough and transitional year

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Germany

More from Europe